{"database": "openregs", "table": "documents", "rows": [["FDA-2008-D-0150-0015", "FDA", "FDA-2008-D-0150", "Guidance for Industry; Availability: Hypertension Indication, Drug Labeling for Cardiovascular Outcome Claims", "Notice", "NAD-Notice of Availability of Data", "2011-03-15T04:00:00Z", 2011, 3, "2011-03-15T04:00:00Z", "2011-05-17T03:59:59Z", "2011-03-16T12:35:04Z", "2011-05945", 0, 0, "0900006480c07f51"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2008-D-0150-0015"], "units": {}, "query_ms": 1.0371520183980465, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}